NCT04948333 2026-03-18Asciminib Treatment Optimization in ≥ 3rd Line CML-CPNovartisPhase 3 Completed199 enrolled 13 charts
NCT04487236 2025-08-11Trial of ZN-A-1041 Enteric Capsules in Patients With HER2-Positive Advanced Solid TumorsSuzhou Zanrong Pharma LimitedPhase 1 Completed61 enrolled